Ratio Revelations: Bristol-Myers Squibb Co (BMY)’s Financial Metrics in the Spotlight

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Bristol-Myers Squibb Co (NYSE: BMY) closed the day trading at $54.71 down -1.03% from the previous closing price of $55.28. In other words, the price has decreased by -$1.03 from its previous closing price. On the day, 11.88 million shares were traded. BMY stock price reached its highest trading level at $55.515 during the session, while it also had its lowest trading level at $54.49.

Ratios:

For a better understanding of BMY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.04. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.24. In the meantime, Its Debt-to-Equity ratio is 3.00 whereas as Long-Term Debt/Eq ratio is at 2.93.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on October 25, 2024, Downgraded its rating to Neutral and sets its target price to $55 from $75 previously.

On October 17, 2024, Bernstein started tracking the stock assigning a Mkt Perform rating and target price of $56.

Barclays Downgraded its Overweight to Equal Weight on July 29, 2024, while the target price for the stock was maintained at $41.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 04 ’24 when Holzer Phil M sold 700 shares for $55.62 per share. The transaction valued at 38,930 led to the insider holds 11,760 shares of the business.

Hirawat Samit bought 1,830 shares of BMY for $100,055 on Nov 01 ’24. The EVP,Chief Med.Offr.,Drug Dev. now owns 62,109 shares after completing the transaction at $54.67 per share. On Nov 04 ’24, another insider, Holzer Phil M, who serves as the Officer of the company, bought 700 shares for $55.62 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMY now has a Market Capitalization of 112117743616 and an Enterprise Value of 154362544128. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34 while its Price-to-Book (P/B) ratio in mrq is 6.47. Its current Enterprise Value per Revenue stands at 3.254 whereas that against EBITDA is 8.056.

Stock Price History:

Over the past 52 weeks, BMY has reached a high of $56.80, while it has fallen to a 52-week low of $39.35. The 50-Day Moving Average of the stock is 5.65%, while the 200-Day Moving Average is calculated to be 13.86%.

Shares Statistics:

Over the past 3-months, BMY traded about 10.86M shares per day on average, while over the past 10 days, BMY traded about 10428560 shares per day. A total of 2.03B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.08% of the company’s shares, while institutions hold 77.05% stake in the company. Shares short for BMY as of 1728950400 were 22501723 with a Short Ratio of 2.07, compared to 1726185600 on 21792101. Therefore, it implies a Short% of Shares Outstanding of 22501723 and a Short% of Float of 1.11.

Dividends & Splits

BMY’s forward annual dividend rate is 2.40, up from 2.4 a year ago. Against a Trailing Annual Dividend Yield of 0.04341534The stock’s 5-year Average Dividend Yield is 3.41.

Most Popular